NewsRx

Search our medical news database

Cardiology

Atherotech Adds Two Members to the Board of Directors

Published in Gastroenterology Week, May 21st, 2007

Atherotech, Inc., a pioneer in cardiodiagnostic cholesterol testing technology renowned for its VAP Cholesterol Test, announced the additions of Laura G. King and Kenneth M. Roe as independent members to its board of directors. Most recently, King served as President and CEO of the $1.2 billion GE Healthcare Interventional Cardiology Business. Roe, currently retired, last served as Regional Vice President and Operations Leader for Quest Diagnostics Incorporated, where he oversaw lab operations exceeding $1 billion in annual revenue.

"We are very pleased to welcome Laura and Ken to Atherotech's board," said David Schreiber, President and CEO of Atherotech. "They both...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gastroenterology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook